Format
Sort by

Send to

Choose Destination

Search results

Items: 5

1.

Mean Platelet Volume Predicts Vascular Access Events in Hemodialysis Patients.

Lano G, Sallée M, Pelletier M, Bataille S, Fraisse M, Berda-Haddad Y, Brunet P, Burtey S.

J Clin Med. 2019 May 4;8(5). pii: E608. doi: 10.3390/jcm8050608.

2.

Hemodialysis vascular graft as a focus of persistent Q fever.

Ernest V, Cammilleri S, Amabile P, Fedi M, Burtey S, Von Kotze C, Pelletier M, Moal V, Guedj E, Perron C, Boustani R, Berland Y, Brunet P, Raoult D, Fournier PE, Jourde-Chiche N.

Infection. 2018 Dec;46(6):881-884. doi: 10.1007/s15010-018-1206-5. Epub 2018 Oct 27.

PMID:
30368731
3.

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.

Brigant B, Metzinger-Le Meuth V, Massy ZA, McKay N, Liabeuf S, Pelletier M, Sallée M, M'Baya-Moutoula E, Paul P, Drueke TB, Burtey S, Metzinger L.

Clin Kidney J. 2017 Aug;10(4):578. doi: 10.1093/ckj/sfx068. Epub 2017 Jul 9.

4.

Indole 3-acetic acid, indoxyl sulfate and paracresyl-sulfate do not influence anemia parameters in hemodialysis patients.

Bataille S, Pelletier M, Sallée M, Berland Y, McKay N, Duval A, Gentile S, Mouelhi Y, Brunet P, Burtey S.

BMC Nephrol. 2017 Jul 26;18(1):251. doi: 10.1186/s12882-017-0668-5. Erratum in: BMC Nephrol. 2017 Oct 4;18(1):306.

5.

Serum microRNAs are altered in various stages of chronic kidney disease: a preliminary study.

Brigant B, Metzinger-Le Meuth V, Massy ZA, McKay N, Liabeuf S, Pelletier M, Sallée M, M'Baya-Moutoula E, Paul P, Drueke TB, Burtey S, Metzinger L.

Clin Kidney J. 2017 Feb;10(1):30-37. doi: 10.1093/ckj/sfw060. Epub 2016 Jul 4. Retraction in: Clin Kidney J. 2017 Aug;10 (4):578.

Supplemental Content

Loading ...
Support Center